ストックスクリーナーアプリを入手
21.19
9.33%
-2.18
アフターアワーズ：
21.16
-0.03
-0.14%
前日終値:
$23.37
開ける：
$22.77
24時間の取引高:
3.49M
Relative Volume:
2.32
時価総額：
$1.99B
収益：
$1.13B
当期純損益:
$62.75M
株価収益率:
33.63
EPS:
0.63
ネットキャッシュフロー:
$170.92M
1週間 パフォーマンス:
-8.78%
1か月 パフォーマンス:
-6.07%
6か月 パフォーマンス:
+27.57%
1年 パフォーマンス:
-34.80%
1日の値動き範囲:
$20.35
$22.80
1週間の範囲:
$20.35
$23.77
52週間の値動き範囲:
$13.39
$30.42
Progyny Inc Stock (PGNY) Company Profile
PGNY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
21.19 | 1.99B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
380.64 | 364.02B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
404.58 | 92.63B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
333.46 | 89.43B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
66.97 | 85.34B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
249.53 | 31.20B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-11-13 | ダウングレード | Truist | Buy → Hold |
| 2024-09-19 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-08-07 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-05-10 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-09-27 | 開始されました | Canaccord Genuity | Buy |
| 2023-05-22 | 開始されました | BTIG Research | Buy |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-01-05 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | 開始されました | Truist | Buy |
| 2021-12-02 | 開始されました | Jefferies | Buy |
| 2021-11-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-09-30 | 開始されました | Berenberg | Buy |
| 2021-08-12 | 開始されました | Barclays | Overweight |
| 2021-06-02 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-04-29 | 再開されました | JP Morgan | Overweight |
| 2021-03-10 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-07-01 | 開始されました | SVB Leerink | Outperform |
| 2020-06-02 | 開始されました | Guggenheim | Buy |
| 2019-11-19 | 開始されました | Citigroup | Buy |
| 2019-11-19 | 開始されました | Goldman | Buy |
| 2019-11-19 | 開始されました | JP Morgan | Overweight |
| 2019-11-19 | 開始されました | Piper Jaffray | Overweight |
| 2019-11-19 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Progyny Inc (PGNY) 最新ニュース
PGNY Q1 Earnings Call: Product Expansion, Member Growth, and Guidance Raised - Yahoo Finance
Progyny, Inc. Reports Strong Q1 2025 Results - TipRanks
Progyny Inc (PGNY) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions - Yahoo
Earnings call transcript: Progyny Q1 2025 beats EPS estimates - Investing.com
Progyny: Q1 Earnings Snapshot - Norwalk Hour
Progyny Q1 2025 Earnings Call Transcript - MarketBeat
Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Progyny Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Progyny, Inc. Q1 Profit Beats Estimates - Nasdaq
Progyny (PGNY) Surpasses Q1 Revenue Expectations with Robust Growth | PGNY Stock News - GuruFocus
Progyny (NASDAQ:PGNY) Posts Better-Than-Expected Sales In Q1, Provides Optimistic Revenue Guidance for Next Quarter - Yahoo Finance
Progyny, Inc. Announces First Quarter 2025 Results - The Manila Times
(PGNY) PROGYNY INC. Forecasts Q2 Revenue Range $310M$325M - marketscreener.com
Progyny Inc (PGNY) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Progyny (PGNY) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
BlackRock, Inc. Adjusts Holdings in Progyny Inc: A Strategic Portfolio Move - GuruFocus
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building - ADVFN
Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Progyny: Q3 Earnings Snapshot - marketscreener.com
At US$22.90, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely? - simplywall.st
Progyny, Inc. Announces Details for Its First Quarter 2025 Resul - GuruFocus
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report - The Manila Times
Progyny, Inc. to Report Q1 2025 Financial Results on May 8, 2025 - Nasdaq
Progyny Sets Date for Q1 2025 Earnings: What Fertility Healthcare Investors Should Watch - Stock Titan
(PGNY) Technical Data - news.stocktradersdaily.com
Why Progyny (PGNY) is Poised to Beat Earnings Estimates Again - Yahoo Finance
Progyny Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Progyny Rings the Opening Bell - Nasdaq
Progyny names Melissa Cummings as COO - MSN
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY) - Yahoo Finance
Progyny (PGNY) Boosts Leadership Team with COO and Chief Product - GuruFocus
Progyny names new COO and CPO to drive growth By Investing.com - Investing.com India
Progyny Names Melissa Cummings COO - marketscreener.com
Progyny names new COO and CPO to drive growth - Investing.com
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer | PGNY Stock News - GuruFocus
Progyny Names Healthcare Veterans Melissa Cummings as Chief - GlobeNewswire
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer - TradingView
Progyny to Host Events Honoring Individuals, Families and Infert - GuruFocus
Progyny to Host Events Honoring Individuals, Families and - GlobeNewswire
Progyny Takes Over Nasdaq & Empire State Building for Groundbreaking Fertility Awareness Week - Stock Titan
Progyny announces director Dr. Fred Cohen to step down By Investing.com - Investing.com Canada
Form DEFA14A Progyny, Inc. - StreetInsider
Progyny announces director Dr. Fred Cohen to step down - Investing.com Australia
Progyny Director Fred Cohen to Step Down - TipRanks
SEC Form DEFA14A filed by Progyny Inc. - Quantisnow
Progyny, Inc. Announces Fred E. Cohen Notifies the Board of Directors of His Decision Not to Stand for Reelection At the 2025 Annual Meeting of Stockholders - marketscreener.com
Assisted Reproductive Technology Market Forecast Report and Company Analysis 2025-2033 Featuring Thermo Fisher Scientific, Sumitomo Mitsui, CooperSurgical, Fujifilm, Merck, Progyny, Cosmos BiomedicalResearchAndMarkets.com - Bluefield Daily Telegraph
The Broken Brown Egg and Progyny Announce the 2025 - GlobeNewswire
Major Fertility Support: Progyny's New Grant Removes Barriers for BIPOC Family Building - Stock Titan
Progyny's SWOT analysis: fertility benefits provider faces growth hurdles - Investing.com
Progyny Inc (PGNY) 財務データ
収益
当期純利益
現金流量
EPS
1.95%
0.29%
大文字化:
|
ボリューム (24 時間):